Long-Term Launch of COVID Labs on January 9 to Revolutionize Medical Industries
As of January 9, BioDAO launched Long COVID Labs (COVID).
BIO Protocol is the 63rd project in the Binance Launchpool and it was on the 3rd day of the year when Binance enabled BIO listing.
According to information published by BIO Protocol in a new post regarding X, which Twitter considers, The Labs is expanding on January 9 and is looking to launch a treatment using DeSci technology.
The project will be tokenized by COV and will be participated in by collaborators including current and former Stanford researchers. 1% of the project’s total token supply will be allocated to BIO holders who participate in the auction.
Long Covid Labs Vision
According to a project summary they shared via X, they envisioned the following details, saying that even if Covid-19 is no longer in the media, it is still present in people physically - and they explained that about 20% of patients who have fully recovered still have remnants of the viral spike protein in their bloodstream for a long time.
Furthermore, they also noted that 40 percent of patients eligible for a long COVID diagnosis have chronic conditions.
Reports indicate that the Long Covid Labs Company has been formed to address these issues and have a greater vision.
Long Covid Treatment
Developing treatments for people around the world that will reach billions
Changing the future of medicine.
The project founders include the following professionals:
Rohan Dixit - A serial entrepreneur in the health industry, Rohan was a neuroscience researcher at Stanford University and the MGH Martinus Center, and a long Covid patient.
Ruth Ann Crystal (MD) - A medical entrepreneur at Stanford University, she is also a leading contributor to Covid-19 newsletters.
Jacob Glenville - Founder of Syntifaxi, Computational Immunology Engineer.
Anneliese Barron - Professor of Bioengineering at Stanford University who develops new drugs.
The largest decentralized clinical trial network
In Series X, the project turns out to be the largest decentralized clinical trial network ever built, using machine learning that:
recognizes directions
Improves experiences
Recommends individualized treatments
The project also noted that while medicine has been dominated by big pharma for decades, which has profited from long, expensive processes that prioritize investors over patients, Long Covid Labs will change that model and focus on patients.
Participation
The project uses a DAO model where users/patients own governance tokens (COVID) that have voting power over proposals made, funding recommended research, and oversight of funds collected.
There are two ways you can get COVID codes:
Donate through search
Stakeholders buy COVID tokens directly to fund research
BIO Protocol was launched in the last month of 2024 as Project 63 of Binance Launchpool.